Order results by:
| Issue | Title | |
| Vol 16, No 1 (2023) | Efficiency of Levilimab in patients with moderate and severe COVID-19 | Abstract similar documents |
| Yu. M. Gomon, V. V. Strizheletsky, I. G. Ivanov, Yu. E. Balykina, M. V. Ermolyev, A. S. Kolbin, M. V. Livshits, T. A. Usmanova, A. M. Fakhrutdinova, Yu. S. Konstantinova, A. P. Gubanov | ||
| "... of moderate and severe COVID-19 based on real world data (RWD). Material and methods. A single-center ..." | ||
| Vol 13, No 4 (2020) | Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm | Abstract similar documents |
| M. Yu. Frolov, A. S. Salasyuk, V. A. Rogov | ||
| "... )-6 drugs: tocilizumab, olokizumab, and levilimab in patients with severe COVID-19 and cytokine storm ..." | ||
| Vol 15, No 1 (2022) | A systematic review of real-world clinical practice data in COVID-19: non-interventional studies | Abstract similar documents |
| S. A. Mishinova, Yu. M. Gomon, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov | ||
| "... Introduction. As defined by the Food and Drug Administration, real-world data (RWD) is data ..." | ||
| Vol 16, No 2 (2023) | Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy | Abstract similar documents |
| M. V. Zhuravleva, V. P. Chulanov, Yu. V. Gagarina, E. A. Shabalina | ||
| "... or their combinations vs standard therapy in patients with mild and moderate-severe COVID-19 in order to prevent ..." | ||
| Vol 14, No 2 (2021) | Pharmacoeconomic aspects of the therapy for moderate and severe psoriatic arthritis | Abstract similar documents |
| A. V. Rudakova, D. G. Tolkacheva, V. D. Sokolova | ||
| "... среднетяжелой и тяжелой степени на основе результатов сетевого метаанализа рандомизированных клинических ..." | ||
| Vol 15, No 3 (2022) | The role of real world data and real world evidence in health technology assessment | Abstract similar documents |
| E. A. Novoderezhkina, S. К. Zyryanov | ||
| "... Real world data (RWD) and real world evidence (RWE) is one of the most rapidly developing areas ..." | ||
| Vol 16, No 4 (2023) | Peculiarities of real-world data application for health technology assessment in Asian countries | Abstract similar documents |
| B. B. Kondratyeva, F. V. Gorkavenko, V. V. Omelyanovskiy | ||
| "... The article is devoted to the study of regulatory approaches to the sphere of real-world data (RWD ..." | ||
| Vol 16, No 4 (2023) | Legal particularities of AI technology usage in real-world data formation | Abstract similar documents |
| V. S. Malichenko, A. O. Gadzhieva, N. I. Platonova, A. Yu. Solovieva-Oposhnyanskaya | ||
| Vol 16, No 2 (2023) | Real-world data: principles of use in decision making and in health technology assessment | Abstract similar documents |
| V. V. Omelyanovskiy, F. V. Gorkavenko, N. V. Ignatyeva, P. A. Mukhortova, O. R. Ryzhova, T. S. Teptsova, A. A. Kingshott, B. B. Kondratyeva | ||
| "... The use of real-world data (RWD) and real-world evidence (RWE) in process of improving public ..." | ||
| Vol 8, No 2 (2015) | CLINICAL EFFICIENCY AND THE PHARMACOECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY AT PATIENTS WITH MILD AND MODERATE ALLERGIC BRONCHIAL ASTHMA | Abstract similar documents |
| Elena Albertovna Sobko, Natalya Vladimirovna Gordeeva, Angelina Yurievna Kraposhina, Irina Anatolyevna Soloveva, Svetlana Vladimirovna Chubarova, Olga Petrovna Ishenko, Irina Vladimirovna Demko, Maria Michailovna Loktionova | ||
| "... аллергенспецифической иммунотерапии (АСИТ) у пациентов с аллергической бронхиальной астмой легкого и среднетяжелого ..." | ||
| Vol 12, No 4 (2019) | Pharmacoeconomic analysis of using biological agents for uncontrolled moderate-to-severe atopic asthma in the Russian Federation | Abstract similar documents |
| S. K. Zyryanov, I. N. Diyakov, S. N. Avdeev | ||
| "... , меполизумаб и реслизумаб при лечении больных неконтролируемой среднетяжелой и тяжелой атопической бронхиальной ..." | ||
| Vol 15, No 1 (2022) | Efficacy of targeted drugs for the treatment of adults with moderate-to-severe plaque psoriasis in the Russian Federation: a systematic literature review update | Abstract similar documents |
| V. D. Sokolova, N. A. Sableva, V. V. Mladov, D. G. Tolkacheva | ||
| "... опубликованных результатов РКИ, изучающих эффективность терапии взрослых пациентов со среднетяжелым и тяжелым ..." | ||
| Vol 14, No 3 (2021) | Pharmacoeconomic aspects of COVID-19 treatment | Abstract similar documents |
| I. V. Rogova, E. A. Zhidkova, I. A. Popova, A. V. Zaborovskiy, K. G. Gurevich | ||
| "... The article provides an overview of global trends in various treatment approaches for COVID-19 ..." | ||
| Vol 13, No 2 (2020) | COVID-19 pandemic: protective role of vitamin D | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, G. Kh. Gabdulina | ||
| "... Introduction. The COVID-19 pandemic revealed the vulnerability of the general population ..." | ||
| Vol 15, No 4 (2022) | Dietary factors influencing the COVID-19 epidemic process | Abstract PDF (Eng) similar documents |
| S. V. Ponomarenko | ||
| "... Coronavirus and identify factors that correlate withthe reduction in the severity of the consequences of COVID ..." | ||
| Vol 14, No 2 (2021) | Impact of disease information (Ebola and COVID-19) on the pharmaceutical sector in Russia and USA | Abstract similar documents |
| E. A. Fedorova, D. O. Afanasyev, A. V. Sokolov, M. P. Lazarev | ||
| "... and methods. The empirical base of the study includes more than 700 thousand tweets on Ebola and COVID-19 ..." | ||
| Vol 14, No 3 (2021) | COVID-19 pandemic prediction model based on machine learning in selected regions of the Russian Federation | Abstract similar documents |
| D. V. Gavrilov, R. V. Abramov, А. V. Kirilkina, А. А. Ivshin, R. E. Novitskiy | ||
| "... Background. Prediction of the new coronavirus infection (COVID-19) spread is important to take ..." | ||
| Vol 14, No 1 (2021) | Clinical and economic constituents of the application of dexamethasone and tocilizumab in the therapy for severe conditions in patients with COVID-19 | Abstract similar documents |
| O. V. Zhukova, A. L. Khokhlov | ||
| "... Background. Severe forms of COVID-19 are associated with the development of a cytokine storm ..." | ||
| Vol 14, No 2 (2021) | Chemoreactome screening of pharmaceutical effects on SARS-CoV-2 and human virome to help decide on drug-based COVID-19 therapy | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin, Yu. I. Zhuravlev | ||
| "... and safe drug-based treatment for COVID-19. Another approach seems promising: to reprofile ..." | ||
| Vol 15, No 2 (2022) | Clinical study of real-time polymerase chain reaction test kit for SARS-CoV-2 ribonucleic acids detection | Abstract similar documents |
| M. Yu. Dmitryukova, A. A. Golod, M. E. Senina, A. E. Gushchin | ||
| Vol 16, No 1 (2023) | Non-invasive respiratory support in patients with severe community-acquired pneumonia | Abstract similar documents |
| S. V. Korotchenko, D. I. Korabelnikov | ||
| "... forms of COVID-19. At the beginning of COVID-19 pandemic the starting respiratory protocol suggested ..." | ||
| Vol 13, No 4 (2020) | Peptides contained in the composition of Laennec that contribute to the treatment of hyperferritinemia and iron overload disorders | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, V. A. Maksimov, A. G. Chuchalin, V. G. Zgoda, А. N. Gromov, O. V. Tikhonova | ||
| Vol 14, No 4 (2021) | Development of the system of state financing of Compulsory Health Insurance | Abstract similar documents |
| А. V. Larionov, S. V. Russkikh, S. V. Maslennikov | ||
| Vol 15, No 3 (2022) | Economic burden of the novel coronavirus infection: a systematic review | Abstract similar documents |
| V. M. Timiryanova, I. A. Lakman, N. Sh. Zagidullin, D. F. Gareeva | ||
| "... Background. The sudden emergence and rapid spread of the novel coronavirus infection (COVID-19 ..." | ||
| Vol 15, No 3 (2022) | Funding for coronavirus health worker payments | Abstract similar documents |
| I. Yu. Bocharova, A. Yu. Rymanov | ||
| "... Objective: to conduct an analysis of the channels, the volume of COVID payments to medical workers ..." | ||
| Vol 10, No 1 (2017) | BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS | Abstract similar documents |
| E. A. Pyadushkina | ||
| "... (ведолизумаба и различных ингибиторов ФНО-α) у взрослых пациентов со среднетяжелым или тяжелым активным язвенным ..." | ||
| Vol 10, No 2 (2017) | COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD | Abstract similar documents |
| E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov, N. L. Bondarenko, A. V. Karaulov | ||
| "... среднетяжелым течением (ОФВ1 ≥50%) не является достаточно эффективной, использование ЛП вилантерол + умеклидиния ..." | ||
| Vol 10, No 4 (2017) | PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION | Abstract similar documents |
| M. Yu. Frolov, V. A. Rogov | ||
| "... среднетяжелой гемофилии А является профилактическая терапия VIII фактором свертывания. Расширение практики ..." | ||
| Vol 14, No 4 (2021) | Peptides of Laennec® preparation that contribute to the elimination of endotheliopathy | Abstract similar documents |
| I. Yu. Torshin, О. А. Gromova, V. G. Zgoda, А. G. Chuchalin, V. А. Maksimov, О. V. Tikhonova | ||
| "... important in the rehabilitation of patients who have recovered from COVID-19. ..." | ||
| Vol 17, No 3 (2024) | Biologically active supplements overview: regulation, market trends, application, and health impact | Abstract similar documents |
| A. M. Stepanova, A. N. Plutnitskiy, E. V. Gameeva | ||
| "... . The public health crisis caused by the COVID-19 pandemic as well as concerns about vaccines in many parts ..." | ||
| Vol 16, No 1 (2023) | Systematic computer analysis of the pharmacology of bioflavonoids in the context of increasing the body's antiviral defenses | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. G. Chuchalin | ||
| "... with COVID-19 and other respiratory viral infections were described in detail. Conclusion. Bioflavonoids ..." | ||
| Vol 14, No 2 (2021) | Systematic computer analysis of published literature on nutritional support for vaccination | Abstract similar documents |
| A. G. Chuchalin, I. Yu. Torshin, O. A. Gromova | ||
| "... COVID-19. Additional micronutrient supply contributes to an increase in the effectiveness and safety ..." | ||
| 1 - 33 of 33 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
